KAYNE ANDERSON RUDNICK INVESTMENT MANAGEMENT LLC
Position in GILD — Gilead Sciences, Inc.
CIK 1021223
LOS ANGELES, CA
Position in GILD
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$6,339,235
+$223,402 QoQ
Shares Held
50,176
+14.3% QoQ
Ownership
0.004%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#524
of 2,266 holders
Holding Since
Mar 2020
24 quarters on record
Voting authority
Sole 25%
Shared 74%
None 1%
Common Shares in GILD Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026KAYNE ANDERSON RUDNICK INVESTMENT MANAGEMENT LLC holds $148,204,577 across 14 Drug Manufacturers - General names. GILD ranks #5 (4.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
65,338 | $78,368,363 | |
| 2 | ABBV |
AbbVie Inc.
|
113,217 | $28,489,925 | |
| 3 | JNJ |
Johnson & Johnson
|
57,018 | $14,480,861 | |
| 4 | MRK |
Merck & Co., Inc.
|
64,634 | $8,305,469 | |
| 5 | GILD |
Gilead Sciences, Inc.
This page
|
50,176 | $6,339,235 | |
| 6 | AMGN |
Amgen Inc
|
11,431 | $4,139,392 | |
| 7 | AZN |
Astrazeneca PLC
|
21,789 | $4,131,630 | |
| 8 | NVO |
Novo Nordisk A S
|
28,829 | $1,382,062 |
All Filings in GILD
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $6,339,235 | 50,176 | Shares | Defined | 2026-08-13 | |
| 2026-03-31 | $6,115,833 | 43,882 | Shares | Defined | 2026-05-14 | |
| 2025-12-31 | $5,221,972 | 42,545 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $4,882,890 | 43,990 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $4,373,266 | 39,445 | Shares | Defined | 2025-08-13 | |
| 2025-03-31 | $4,261,597 | 38,033 | Shares | Defined | 2025-05-14 | |
| 2024-12-31 | $18,566 | 201 | Shares | Sole | 2025-02-21 | |
| 2024-09-30 | $13,582 | 162 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $11,046 | 161 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $12,599 | 172 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $14,743 | 182 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $5,695 | 76 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $2,466 | 32 | Shares | Sole | 2023-08-11 | |
| 2023-03-31 | $995 | 12 | Shares | Sole | 2023-05-16 | |
| 2022-06-30 | $2,472 | 40 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $25,385 | 427 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $29,552 | 407 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $27,241 | 390 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $26,855 | 390 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $25,205 | 390 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $22,721 | 390 | Shares | Sole | 2021-02-12 | |
| 2020-09-30 | $2,527 | 40 | Shares | Sole | 2020-11-16 | |
| 2020-06-30 | $3,077 | 40 | Shares | Sole | 2020-08-14 | |
| 2020-03-31 | $2,990 | 40 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||